I hear you. Ken has to balance the short term cash needs with any longer-term gameplan he may want to execute, so I agree some type of licensing in next 3-6 months may be coming to raise at least a little cash. A combination approach of near-term licensing with some amount of upfront cash, combined with some moderate dilution may be the path forward.
I would rather see the company sold than issue 30m shares. I think the company would be foolish to refrain from licensing any HOT indications at all until data is available. I would be okay with licensing one or two now to raise cash and then waiting. I do not see raising a measly $30m with 60% dilution as an acceptable option whatsoever.
Amen, Amen, Amen!
REality bites, but glad to see you have reached it finally.
Market Data 
Markets 
AI
